News
On October 24-26, 2023, in the city of Tashkent (Republic of Uzbekistan) – International Hotel Tashkent the Second Eurasian Forum on the diagnosis and treatment of orphan diseases: “Commonwealth without borders” was…
Scientists studying the mutation of the SARS-CoV-2 virus are constantly discovering more and more new strains of this virus. A new coronavirus “Arcturus” (XVV 1.16) has been discovered – a new, more…
On January 30, 2023, ROSSA’s management was awarded ISO 9001 and ISO 13485 certificates. ISO is an international quality standard. They are being developed for various fields: medicine, IT security, environmental management…
Chronic hepatitis B is one of the main etiological causes of liver failure, cirrhosis and hepatocellular carcinoma worldwide. This condition cannot be completely cured by currently available medications due to the constant…
On December 23, 2022, in Tashkent, in the conference hall of the FRANKFORT Hotel, the Association of Hepatologists of Uzbekistan together with the Association of Biomedical Technologies, with the support of the…
ROSSA took part in the congress and exhibition “Pharma Uzbekistan and Central Asia”, which took place in Tashkent from November 16 to 18, 2022. The event has become an important event for…